Home Zika Virus Mystery Solved

Zika Virus Mystery Solved

Horowitz_ZIKA_Banner copy

Zika Virus Mystery Solved by Analysis of New York Times Propaganda Concealing Scientific Evidence Linking the Pandemic to GM Mosquitoes Loosed in Brazil


Honolulu, HI—A Harvard-trained expert in emerging diseases has charged the New York Times with covering up conflicting interests and defrauding the public while purposely neglecting the most reasonable and obvious scientific explanation for how and why the brain-damaging strain of Zika virus suddenly emerged in Brazil in 2015.


Public records unearthed by whistleblower, Dr. Leonard G. Horowitz, author of the internationally acclaimed text, Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? (Tetrahedron, 1998), evidence heavy investments in an enterprise conducting experiments gone wrong using genetically-modified mosquitoes. Discoveries incriminate NYTimes billionaire owner Carlos Slim.


Horowitz_ZIKA4_Banner“The New York Times has been caught red handed concealing the emergence of the Zika virus from an experiment conducted in Brazil in 2014 using genetically-modified (GM) mosquitoes loosed by the Oxitec Company over which financial control is leveraged by Slim’s investment bankers,” explained Dr. Horowitz.


The doctor began investigating Zika’s origin following news of the dengue fever outbreak on the Big Island where he lives. The author and filmmaker, who has been an influential voice in state and local legislative hearings regarding vaccines,  learned that the State’s chief epidemiologist, Dr. Sarah Park, who Horowitz debated on PBS last year, was solicited by Oxytec agents to release GM mosquitoes without public participation in the decision. He discovered that Oxitec reported testing mutant mosquitoes as an anti-dengue experiment in Brazil.


Mosquito Experiment Oxitec


Oxytec, web intelligence showed, is a subsidiary of Intrexon, largely funded by New York Times investors that continue to hold controlling interests in the companies that stand to profit from the Zika pandemic. According to company records, Oxytec manufactured the GM insects tested in Brazil in 2014, along with dengue vaccine partners in Oxford University’s ISIS innovations, also funded by BlackRock and Evercore Company private equity investors.


NY Times owner Carlos Slim with conflicting interests in diverting the Zika virus mystery away from solid science.

Times owner Carlos Slim is heavily invested in BlackRock, that is administered by ISIS innovations’ and Evercore officials, including Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, Bernard Taylor, co-Vice Chair for the Rockefeller JPMorgan Chase bank. Oxytec’s owner, Intrexon, whose Chairman and CEO is Randal J. Kirk, also on the Board of Directors of ZIOPHARM Oncology, Inc., largely financed by BlackRock, Third Security, LLC and Morgan Stanley.[4]

Screen Shot 2016-02-12 at 12.24.07 PM

Consequently, this financial community’s jaded history must be seriously considered, including racketeering and extorting nations to submit to the enterprise’s financial and political policies, as was witnessed during the 2014 Ebola “emergency” in Liberia.[5]

In light of the facts, circumstances, and scientific evidence at hand, loosing dengue fever and Oxitec’s GM mosquito Zika vectors must be considered a high probability and most reasonable concern until factually disproved.


Circumstantial and Scientific Evidence of Commercial Crime

In 1947, the original Zika virus was isolated from a rhesus monkey in Uganda by Rockefeller financed researchers. The Ugandan government at that time was under British control, and apparently under an Anglo-American contract with OTRAG.[7]) The “weak Zika virus” was then deposited with the Rockefeller Foundation, although it is apparent that Oxford Univ. engaged the secret enterprise with great interest.  Years later, the Zika virus was licensed by the Rockefeller Foundation to the American Type Culture Collection (ATCC) that sells germs to vaccine makers and bioweapons contractors worldwide.


Besides Oxitec, Slim’s money and Taylor’s agents funded a variety of biotech companies and products including influenza, malaria, and dengue fever vaccines, and anti-viral therapeutics involving genetically modified germs.



NYTimes_Zika_articleAccording to the New York Times article (Feb. 6, 2016) “How a Medical Mystery in Brazil Led Doctors to Zika,” there are only two “leading theories” explaining the frightening outbreak. Both hypotheses date Zika’s arrival in Brazil in 2014 via travelers attending the World Cup and Va’a World Sprint canoe race in Rio de Janeiro.


But Horowitz’s “third theory” is based on science, common sense, blatent NYTimes omissions, and the fact that “[i]n April 2014, the Oxitec OX513A [GM mosquito] received technical approval for commercial release in Brazil from the National Technical Commission of Biosecurity (CTNBio),” according to company advertisements.


Oxitec reported, “a large scale release programme” carried out in Jacobina, Bahia following an earlier study there that claimed a 92% Aedes aegypti population reduction in the first area of release in Pedra Branca, Brazil.


Dengue mosquito studyIt is highly probable that the 8% of Aedes aegypti mosquitoes that survived these initial studies mated with the GM mosquitoes, causing viral mutations as warned by researchers Thavara, Tawatsin and Nagao in the journal Epidemiology and Infection (2014 Jun; 142(6): 1245-1258).


In that study, mosquito control increased cases of dengue fever (DF), and the more life threatening dengue hemorrhagic fever (DHF), in areas of high mosquito density where people had been exposed to dengue virus from earlier bites or vaccinations.


Thavara et. al., explained that more deadly virus mutations, and more severe illnesses, occurred “mainly when an individual who has acquired antibodies to one serotype is inoculated with another serotype. It was reported that mosquito control may have increased the incidence of DF and DHF due to age-dependency in manifesting these illnesses or an immunological mechanism.”


“Thavara et. al., precisely described what the world is now witnessing,” Dr. Horowitz explained. “Zika was initially reported to be a ‘weaker strain’ of the dengue virus that suddenly mutated and mysteriously emerged in Brazil after being isolated in Uganda and shipped to America. The new Zika causes never-before-seen brain damage, called microcephaly in infants. This new disease compounds the evidence and reinforces the conclusion reported by Thavara’s group; that such risky GM mosquito experiments are contraindicated in dengue exposed populations.”


The New York Times neglected this most urgent scientific intelligence, Dr. Horowitz said. “This neglect is inconsistent with Occam’s razor analysis. The simplest most obvious and scientifically sound explanation for Zika’s deadly mutation should have been known to, and reported by, the Times reporters.


This evidence of diversionary propaganda embroils Times owners,[1] and GM mosquito vaccine enterprise investors[2] in Oxitec. The consumer fraud in selling and concealing risky biotechnologies is a commercial crime. The deadly experiment gone awry now threatens billions of families that may birth millions of brain damaged children. The social and financial burdens from this growing pandemic are overwhelming.


Parties liable for the damages, according to Dr. Horowitz, include NYTimes major co-investors in Oxitec such as Isis Technologies, Evercore[3], and the BlackRock wealth management group.


Health officials internationally are urged to thoroughly consider the Thavara study, as well as Dr. Horowitz’s report on dengue fever prepared for the Hawaii County Council (viewed online at RevolutionTelevision.net).


Based on this newly acquired intelligence, dengue vaccine and GM mosquito trials should be suspended until the exploding pandemic wanes.


                                                                       – end –


[1] The New York Times is largely controlled by Carlos Slim, who hold substantial investments in the BlackRock Group, the world’s largest money management firm with $4.7 trillion in assets. Mr. Slim’s interests in GM insects and vaccines is verified by his grant of $150 million for central American disease prevention programs in alliance with the Bill and Melinda Gates Foundation.

[2] Oxitec received its seed funding through Oxford University’s Isis Innovation corporate partnership in ISIS Technologies, “a university private commercial interest enterprise.” Isis Innovation spun off Oxitec with financing administered by Bernard Taylor, Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, and Rockefeller JPMorgan Chase co-Vice Chair. Besides Oxitec, Taylor’s agents funded a variety of biotech companies and products including influenza, malaria and dengue fever vaccines, and anti-viral therapeutics.

[3] Ralph Schlosstein is President and Chief Executive Officer of Evercore, and was for almost twenty years was the President of BlackRock, the largest asset management firm in the world, with over $4.7 trillion of assets under management. Mr. Schlosstein co-founded BlackRock in 1988, was a director since the company went public in 1999, chaired BlackRock’s Management Committee, and served on its Executive Committee and its Investment Committee.

[4] JPMorgan Chase & Co. is the parent holding company of Chase(Commerical Bank) and JPMorgan(Investment Bank). John Pierpont Morgan (J.P. Morgan) founded J.P. Morgan & Co., which is the predecessor to Morgan Stanley and JPMorgan Chase. As a result of the Glass-Stegall Act of 1933, J.P. Morgan & Co. was broken up, it spun off its investment banking activities into Morgan Stanley.  J.P. Morgan & Co. continued to operate as a commercial bank. However, in the 1990’s it started to rebuild its investment banking operations. In 2000,  it merged with the Chase Manhattan Bank, and JPMorgan Chase was formed. . . . Today, JPMorgan Chase is the largest Bank in the world with over US$2.6 trillion in assets.  Morgan Stanley continues to operate as an investment bank. John D. Rockefeller, Jr. and the Rockefeller family were the largest shareholders of Chase National Bank.

[5] In just four years, 2011-2013, JPMorgan Chase paid $16 billion in fines, settlements and other litigation expenses. Of the $16 billion JPMorgan Chase has shelled out, about $8.5 billion were for fines and settlements resulting from illegal actions taken by bank executives, according to Richard Eskow at the Campaign for America’s Future, who cited a new report from Joshua Rosner of Graham Fisher & Co.

The U.S. Treasury’s Office of Foreign Assets Control found that JPMorgan had illegally aided dictatorships in Cuba, Sudan, Liberia and Iran, including transferring 32,000 ounces of gold bullion for an Iranian bank.

[6] Related consideration should be given to what was happening in Liberia just prior to the Ebola emergency of 2014. A dictum in medical sociology recognizes that no epidemic in history has ever evolved divorced from major socio-economic and political upheaval. Liberia, in fact, at the time of the Ebola crisis was the world’s most tumultuous and controversial country, socio-politically, economically, and commercially, related to controversial oil drilling operations off its coast. At the same time, money was in-pouring from the International Monetary Fund, due largely to the work of the country’s high-profile president, Ellen Johnson Sirleaf, the winner of the 2011 Nobel Peace Prize, and 2012 Indira Gandhi Prize for Peace, Disarmament and Development.

Ms. Sirleaf, was awarded an honorary Doctor of Law degree from Harvard University in 2011, and the African Gender Award that same year despite being openly opposed to homosexuality. She also won the 2010 Friend of the Media in Africa Award, despite gross corruption in the county persecuting journalists who expose political corruption. In 2014, Ms. Sirleaf was listed as the 70th most powerful woman in the world by Forbes magazine.

According to Wikipedia, which is widely known to be a mouthpiece for Western Intelligence, President Sirleaf offered the United States land to establishment the United States Africa Command (AFRICOM), but America refused her offer, instead using Stuttgart, Germany for the command’s headquarters.

At the same time, Sirleaf strengthened relations with the People’s Republic of China, reaffirming Liberia’s commitment to the One-China policy.[54] In return, China contributed to Liberia’s reconstruction, building several broadcasting transmitters to extend the Liberia Broadcasting System and a new campus for the University of Liberia.[55][56]

So at the same time wooing China and America, two nations vying for military and economic dominance over earth, with both superpowers cranking out increasing amounts of propaganda to justify World War III, Sirleaf encouraged peace and condemned all war-makers!

Most people who have studied history (or Dr. Horowitz’s books and films) know that at the heart of America’s military might, as well as the emerging diseases defense industry, stands the Rockefeller family, the Rockefeller Foundation, Rockefeller-directed American Public Health Association, the American Medical Association, the Rockefeller-directed JPMorgan/Chase banking cartel, and the Rockefeller-controlled ExxonMobil Energy Company.

Consequently, the presence of Rockefeller/JPMorgan/Chase financial investments in Oxitec/Intrexon GM mosquitoes central to the “Zika mystery” chillingly satisfies Occam’s razor analysis as a high probability “vector” for the disorder threatening people internationally.

[7] See Chapter 20 in: Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? Chapter Summaries. It should be known that Ugandan dictator Idi Amin’s rule, “characterized by human rights abuses, political repression, ethnic persecution, extrajudicial killings, nepotism, corruption, and gross economic mismanagement,” did not commence until 1971; and little to no official interest in viral research occurred in Uganda aside from the British-American administration of OTRAG. It is unknown how many people in Uganda and the Congo were killed during OTRAG’s viral experiments during the late 1940s. However, the number of people killed as a result of Idi Amin’s genocideal regime was estimated by international observers to range from 100,000 to 500,000. Quote from: Wikipedia.





Oxytec WEB Site circa 2015:

Oxytec and FKMCD Florida Keys Mosquito Control District | FKMCD are working together to inform the community about the mosquito releases and to answer questions. If FDA agrees that releases can proceed following their review, we anticipate starting in 2015. Oxitec male mosquitoes would be released up to 3 times a week. Project results will be made available to the public




March 2, 2016

While the Ebola and Zika viruses have important differences, the response to the Ebola epidemic demonstrated that the typical, phased approach to medical product development can be accelerated and streamlined as appropriate, for the particular health circumstance; it may be appropriate in certain emergency circumstances to accept a greater than usual degree of uncertainty and risk in order to move rapidly to clinical trials, with the goal of getting safe, effective therapies or vaccine products to patients sooner…No locally transmitted mosquito-borne Zika virus disease cases have been reported in the continental United States to date.

Examining the U.S. Public Health Response to the Zika Virus:

Statement of
Luciana Borio, M.D.
Chief Scientist (Acting)
Food and Drug Administration
Department of Health and Human Services
Before the
Subcommittee on Oversight and Investigations
House Energy and Commerce Committee
U.S. House of Representatives
Examining the Public Health Response to the Zika Virus, March 2, 2016

March 7-9
WHO global consultation of research related to Zika virus infection 7-9 March 2016 Geneva, Switzerland
As part of the implementation of the WHO Research & Development Blueprint for action to prevent epidemics, with financial support from the Bill and Melinda Gates Foundation and the Wellcome Trust.
Preparing for the inevitable—a blueprint for research and development Dr Marie-Paule Kieny, ADG, Health Systems and Innovation Cluster (HSI), WHO
Oxford, UK, 13th April 2016 – An independent survey finds that 64 percent of American adults nationwide, and 66 percent in Florida, support the U.S. Food and Drug Administration approving the use of genetically engineered mosquitoes in areas of the United States that are vulnerable to a Zika outbreak.

JULY 29, 2016

Four cases of Zika infection in Florida are very likely to have been caused by mosquitoes there, the State Department of Health said Friday — the first documented instances of local transmission in the continental United States.  “Zika is now here,” Dr. Thomas R. Frieden, the director of the Centers for Disease Control and Prevention, said at a news briefing. JULY 29, 2016


August 5, 2016

FDA Releases Final Environmental Assessment for Genetically Engineered Mosquito

The FDA has completed the environmental review for a proposed field trial to determine whether the release of Oxitec Ltd.’s genetically engineered (GE) mosquitoes (OX513A) will suppress the local Aedes aegypti mosquito population in the release area at Key Haven, Florida. After considering thousands of public comments, the FDA has published a final environmental assessment (EA) and finding of no significant impact (FONSI) that agrees with the EA’s conclusion that the proposed field trial will not have significant impacts on the environment.

Vaccines and Therapies

There are no vaccines or treatments in advanced development for Zika virus at this time. Development programs for investigational vaccines and therapies are in the very early stages and FDA is actively engaged with NIH and BARDA to help accelerate development programs. FDA stands ready to work with medical product developers to provide technical support and clarify regulatory and data requirements necessary to move products forward in development as quickly as possible

Zika Virus Diagnostic Development

Diagnostic Tests | Available Diagnostics | Support for Diagnostic Development | Zika Virus Reference Materials | LDTs & Zika Virus | Contact FDA
There are no commercially available diagnostic tests cleared by FDA for the detection of Zika virus. FDA encourages commercial diagnostic developers and researchers developing laboratory developed tests (LDTs) for Zika virus to submit an Emergency Use Authorization (EUA) request. FDA will work interactively with developers to support such requests.
FDA has rapidly granted Emergency Use Authorizations for several in vitro diagnostic (IVD) devices. See Emergency Use Authorization for information about Zika virus diagnostics available under EUA.
Page Last Updated: 08/29/2016


Biomedical Advanced Research and Development Authority

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. Learn More >>


BARDA’s Medical Countermeasure Response to Zika

BARDA is collaborating with partners from the Public Health Emergency Medical Countermeasures Enterprise to address medical countermeasure needs for the Zika response both domestically and globally.   BARDA is working to transition medical countermeasure candidates from early development into advanced research and development and then towards FDA approval.
BARDA has developed four strategic goals to address the medical countermeasure needs for the Zika response:
Prevent Zika virus infection through new vaccines
Detect acute and previous Zika virus infections through new rapid diagnostics
Ensure a blood supply safe from Zika virus through use of screening tests for donated blood and virus inactivation in blood products
Activate our National Medical Countermeasure Response Infrastructure to help medical countermeasure developers
To implement these strategic goals, BARDA is building on existing and new partnerships and lessons learned from the H1N1 and Ebola responses.

Florida’s Zika undercount hides extent of virus’ spread, experts say
September 10, 2016 [ 8 cases weren’t reported- oh my god we have a problem of vast proportions!]

“I don’t think the message has been strong enough, in terms of ‘We have a problem,’” said Arthur Caplan, director of medical ethics for New York University Langone Medical Center.

Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy

Mara Gambineri, a spokeswoman, said the health department tracks those cases “as they are still important for us to be aware of, but the cases are not reported in our case counts. The department reports cases of Florida residents.”

Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
That means there have been at least 64 local Zika infections in Florida this year, not the 56 cases reported so far by the health department.

Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
The vast majority of infections in Florida have been imported by residents who caught the virus while traveling abroad in places where Zika is widespread. Statewide, health officials have confirmed 700 travel-related cases, including 80 pregnant women, as of Sept. 9.

After announcing on Sept. 1 that mosquitoes in three Miami Beach locations had tested positive for Zika — a first in the nation — Florida’s Department of Agriculture and Consumer Services identified only one of the places: Miami Beach Botanical Garden, which had closed three days prior. A fourth batch of mosquitoes in Miami Beach that tested positive for Zika was announced on Friday.

The agriculture department has refused to identify all locations, citing exemptions under Florida statutes governing the sharing of confidential or exempt information and investigations into the spread of the virus, said Jennifer Meale, a spokeswoman.


Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy

Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy

Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
Moderna gains BARDA Zika vax funding; closes $474M funding round

by Ben Adams |
Sep 7, 2016 8:05am
Moderna gains BARDA Zika vax funding; closes $474M funding round | FierceBiotech
Moderna is edging toward a total $2 billion in funding after just 5 years of life after announcing a major new funding round–which coincides with a potential $125 million BARDA grant to help fund its mRNA Zika vaccine research.

Moderna currently has around $1.4 billion in cash on its balance sheet and the potential for over $230 million of extra funds from grants funnelled through a number of charitable and government bodies, including the Bill & Melinda Gates Foundation and BARDA–the U.S. government’s emergency health department.